Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
George S. Baillie, Gonzalo S. Tejeda, Michy P. Kelly
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 10, pp. 770-796
Open Access | Times Cited: 281

Showing 1-25 of 281 citing articles:

Subcellular Organization of the cAMP Signaling Pathway
Manuela Zaccolo, Anna Zerio, Miguel J. Lobo
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 278-309
Open Access | Times Cited: 209
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Qinyao Wei, Yun Qian, Jun Yu, et al.
Oncogene (2020) Vol. 39, Iss. 39, pp. 6139-6156
Open Access | Times Cited: 143
Emerging Role of cAMP/AMPK Signaling
Muhammad Aslam, Yury Ladilov
Cells (2022) Vol. 11, Iss. 2, pp. 308-308
Open Access | Times Cited: 143
Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling
Selma E. Anton, Charlotte Kayser, Isabella Maiellaro, et al.
Cell (2022) Vol. 185, Iss. 7, pp. 1130-1142.e11
Open Access | Times Cited: 129
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
Andreas Friebe, Peter Sandner, Achim Schmidtko
Naunyn-Schmiedeberg s Archives of Pharmacology (2019) Vol. 393, Iss. 2, pp. 287-302
Open Access | Times Cited: 111
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 107
Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors
Wesam S. Ahmed, Anupriya M. Geethakumari, Kabir H. Biswas
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111128-111128
Open Access | Times Cited: 106
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
Jonathan E. Phillips
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 100
Advances in the Development of Phosphodiesterase-4 Inhibitors
Ting Peng, Baowen Qi, Jun He, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 10594-10617
Closed Access | Times Cited: 80
cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases
Jordan J. S. VerPlank, Sylwia D. Tyrkalska, Angeleen Fleming, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 25, pp. 14220-14230
Open Access | Times Cited: 77
Alcohol and the brain: from genes to circuits
Gábor Egervári, Cody A. Siciliano, Ellanor L. Whiteley, et al.
Trends in Neurosciences (2021) Vol. 44, Iss. 12, pp. 1004-1015
Open Access | Times Cited: 72
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
Dean Paes, Melissa Schepers, Ben Rombaut, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1016-1049
Open Access | Times Cited: 67
Soluble GC stimulators and activators: Past, present and future
Peter Sandner, Markus Follmann, Eva Becker‐Pelster, et al.
British Journal of Pharmacology (2021) Vol. 181, Iss. 21, pp. 4130-4151
Open Access | Times Cited: 67
The Hippo Signaling Pathway in Drug Resistance in Cancer
Renya Zeng, Jixin Dong
Cancers (2021) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 60
PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
Claire Lugnier, Hayder M. Al‐kuraishy, Éric Rousseau
Biochemical Pharmacology (2021) Vol. 185, pp. 114431-114431
Open Access | Times Cited: 60
Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
Rima Kamel, Jérôme Leroy, Grégoire Vandecasteele, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 2, pp. 90-108
Closed Access | Times Cited: 50
Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
Andrey D. Bondarev, Misty M. Attwood, Jörgen Jönsson, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 43
African Swine Fever Virus EP364R and C129R Target Cyclic GMP-AMP To Inhibit the cGAS-STING Signaling Pathway
Niranjan Dodantenna, Lakmal Ranathunga, W. A. Gayan Chathuranga, et al.
Journal of Virology (2022) Vol. 96, Iss. 15
Open Access | Times Cited: 39
The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
Raymond L. Benza, Ekkehard Grünig, Peter Sandner, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230183-230183
Open Access | Times Cited: 12
Phosphodiesterase Type 4 Inhibition in CNS Diseases
Arjan Blokland, Pim R.A. Heckman, Tim Vanmierlo, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 12, pp. 971-985
Open Access | Times Cited: 55
Adenosine receptor antagonists: Recent advances and therapeutic perspective
Anjali Saini, Rajiv Patel, Sobhi Gaba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113907-113907
Closed Access | Times Cited: 49
Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities
Arun Samidurai, Lei Xi, Anindita Das, et al.
Pharmacology & Therapeutics (2021) Vol. 226, pp. 107858-107858
Open Access | Times Cited: 41
Nanotechnology Tools Enabling Biological Discovery
Carolina Salvador-Morales, Piotr Grodzinski
ACS Nano (2022) Vol. 16, Iss. 4, pp. 5062-5084
Closed Access | Times Cited: 33
The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
Claire Lugnier
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10616-10616
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top